z-logo
open-access-imgOpen Access
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia
Author(s) -
Earle Bain,
Laura Shafner,
David P. Walling,
Ahmed A. Othman,
Christy ChuangStein,
John C. Hinkle,
Adam Hanina
Publication year - 2017
Publication title -
jmir mhealth and uhealth
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.356
H-Index - 50
ISSN - 2291-5222
DOI - 10.2196/mhealth.7030
Subject(s) - medicine , clinical trial , ambulatory , dosing , physical therapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom